Sale!

ALAS2 Gene Protoporphyria Erythropoietic X-Linked Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ALAS2 gene protoporphyria erythropoietic X-linked genetic test is a specialized diagnostic procedure designed to identify mutations in the ALAS2 gene, which are linked to X-linked protoporphyria (XLP). XLP is a rare form of erythropoietic protoporphyria (EPP) that affects the body’s ability to produce heme, an essential component of hemoglobin. Individuals with mutations in the ALAS2 gene may experience photosensitivity, causing painful skin reactions to sunlight, and in some cases, liver complications.

This test is crucial for individuals with a family history of XLP or those exhibiting symptoms, as it can confirm the diagnosis, allowing for appropriate management and counseling. Conducted at DNA Labs UAE, the test provides a comprehensive analysis of the ALAS2 gene to identify any genetic mutations associated with the condition.

The cost of the ALAS2 gene protoporphyria erythropoietic X-linked genetic test at DNA Labs UAE is 4400 AED. Given the specialized nature of the test and its importance in diagnosing a rare genetic condition, the price reflects the advanced technology and expertise required to accurately identify mutations in the ALAS2 gene. By opting for this test, individuals gain crucial insights into their genetic makeup, enabling informed decisions regarding their health and the management of X-linked protoporphyria.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ALAS2 Gene Protoporphyria erythropoietic X-linked Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for ALAS2 Gene Protoporphyria, erythropoietic, X-linked NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Protoporphyria, erythropoietic, X-linked

Test Details

ALAS2 gene protoporphyria, erythropoietic, X-linked NGS genetic test is a genetic test that is used to detect mutations in the ALAS2 gene. This gene is responsible for encoding an enzyme called aminolevulinate synthase 2, which plays a crucial role in the production of heme, an essential component of hemoglobin.

Protoporphyria is a group of rare genetic disorders characterized by a deficiency of certain enzymes involved in heme production. In erythropoietic protoporphyria, there is a deficiency of ferrochelatase, another enzyme involved in heme synthesis. This deficiency leads to the accumulation of protoporphyrin in the body, causing photosensitivity and other symptoms.

The ALAS2 gene is located on the X chromosome, making the condition X-linked. This means that the disorder primarily affects males, while females are typically carriers of the mutated gene.

The NGS (Next-Generation Sequencing) technique used in this genetic test allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of genetic variations.

The ALAS2 gene protoporphyria, erythropoietic, X-linked NGS genetic test can help in confirming a diagnosis of erythropoietic protoporphyria caused by mutations in the ALAS2 gene. It can also be used for carrier testing in females with a family history of the condition. Additionally, this test can provide valuable information for genetic counseling and family planning.

It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors. They can provide appropriate guidance and support based on the results of the test.

Test Name ALAS2 Gene Protoporphyria erythropoietic X-linked Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ALAS2 Gene Protoporphyria, erythropoietic, X-linked NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Protoporphyria, erythropoietic, X-linked
Test Details

ALAS2 gene protoporphyria, erythropoietic, X-linked NGS genetic test is a genetic test that is used to detect mutations in the ALAS2 gene. This gene is responsible for encoding an enzyme called aminolevulinate synthase 2, which plays a crucial role in the production of heme, an essential component of hemoglobin.

Protoporphyria is a group of rare genetic disorders characterized by a deficiency of certain enzymes involved in heme production. In erythropoietic protoporphyria, there is a deficiency of ferrochelatase, another enzyme involved in heme synthesis. This deficiency leads to the accumulation of protoporphyrin in the body, causing photosensitivity and other symptoms.

The ALAS2 gene is located on the X chromosome, making the condition X-linked. This means that the disorder primarily affects males, while females are typically carriers of the mutated gene. The NGS (Next-Generation Sequencing) technique used in this genetic test allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of genetic variations.

The ALAS2 gene protoporphyria, erythropoietic, X-linked NGS genetic test can help in confirming a diagnosis of erythropoietic protoporphyria caused by mutations in the ALAS2 gene. It can also be used for carrier testing in females with a family history of the condition. Additionally, this test can provide valuable information for genetic counseling and family planning.

It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors. They can provide appropriate guidance and support based on the results of the test.